Catalyst Pharmaceuticals, Inc. (CPRX)
23.23
-0.16
(-0.68%)
USD |
NASDAQ |
Mar 13, 16:00
23.22
-0.01
(-0.04%)
After-Hours: 20:00
Catalyst Pharmaceuticals EPS Diluted (Quarterly) : 0.4136 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.172 |
| Assertio Holdings, Inc. | 1.612 |
| Ionis Pharmaceuticals, Inc. | -1.414 |
| Karyopharm Therapeutics, Inc. | -5.708 |
| Krystal Biotech, Inc. | 1.699 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 52.70M |
| Revenue (Quarterly) | 152.61M |
| Total Expenses (Quarterly) | 99.92M |
| Enterprise Value | 2.131B |
| Gross Profit Margin (Quarterly) | 76.71% |
| Profit Margin (Quarterly) | 34.53% |
| Earnings Yield | 7.25% |
| Operating Earnings Yield | 8.72% |
| Normalized Earnings Yield | 7.227 |